Cystic fibrosis gene mutations deltaF508 and 394delTT in patients with chronic sinusitis in Finland.

Previous studies have shown that cystic fibrosis (CF) gene mutations are linked to several severe chronic infections. Chronic sinusitis is one condition that may well be influenced by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. We studied two prevalent CF mutations (AF508 and 394delTT) in a population with a low incidence of CF. The carrier frequency of the CF mutations in the Finnish population is approximately 1 in 80. We examined DNA specimens from 127 chronic sinusitis patients and found one patient who was heterozygous for 394delTT gene mutation. None of the DNA specimens had any AF508 mutation. This study shows that in a population with a low incidence of CF there was no abnormal carrier distribution of the two most common CF gene mutations in a group of chronic sinusitis patients. Routine screening of sinusitis patients for CF mutations provides no additional information on the etiology of chronic sinusitis.

[1]  A. Togias,et al.  Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. , 2000, JAMA.

[2]  M. Schwarz,et al.  Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. , 1998, The New England journal of medicine.

[3]  T. Flotte,et al.  A Phase I/II Study of tgAAV-CF for the Treatment of Chronic Sinusitis in Patients with Cystic Fibrosis. Stanford University, Stanford, California , 1998 .

[4]  N. Jones,et al.  Cystic fibrosis transmembrane conductance regulator gene mutations in severe nasal polyposis. , 1997, Clinical otolaryngology and allied sciences.

[5]  T. Platts-Mills,et al.  Chronic sinusitis: risk factors for extensive disease. , 1997, The Journal of allergy and clinical immunology.

[6]  J. Corey,et al.  Pediatric Sinusitis: A Literature Review with Emphasis on the Role of Allergy , 1997, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[7]  D. Kennedy.  Medical Management of Sinusitis: Educational Goals and Management Guidelines , 1995, The Annals of otology, rhinology & laryngology. Supplement.

[8]  V. Lund,et al.  Quantification for Staging Sinusitis , 1995 .

[9]  V. Lund,et al.  Quantification for staging sinusitis. The Staging and Therapy Group. , 1995, The Annals of otology, rhinology & laryngology. Supplement.

[10]  R. Crystal,et al.  Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis , 1994, Nature Genetics.

[11]  H. Sasaki,et al.  Delta F508 mutation of cystic fibrosis gene is not found in chronic bronchitis with severe obstruction in Japan. , 1992, The American review of respiratory disease.

[12]  J. Marshall,et al.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.

[13]  J. Lafitte,et al.  Abnormal distribution of cystic fibrosis ΔF508 allele in adults with chronic bronchial hypersecretion , 1990, The Lancet.

[14]  J. Thomsen,et al.  Nasal polyps in cystic fibrosis , 1977, The Journal of Laryngology & Otology.

[15]  X. Estivill,et al.  Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations , 1997 .

[16]  I. Melén,et al.  Chronic maxillary sinusitis. Definition, diagnosis and relation to dental infections and nasal polyposis. , 1986, Acta oto-laryngologica.

[17]  W. Schlenter,et al.  [Diagnosis of inflammatory paranasal sinus diseases]. , 1982, Archives of oto-rhino-laryngology.

[18]  P. di Sant'Agnese,et al.  Cystic fibrosis in adults: 75 cases and a review of 232 cases in the literature , 1979 .